The US FDA has not yet found an association between oral bisphosphonates and the risk of atypical subtrochanteric femur fractures,

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2010年 / 1293卷 / 1期
关键词：
Public Health; Clinical Trial; Osteoporosis; Bisphosphonates; Healthcare Professional;
D O I：
10.2165/00128415-201012930-00004
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2 / 2
相关论文
共 31 条
  • [31] Is there a reduction in risk of revision when 36-mm heads instead of 32 mm are used in total hip arthroplasty for patients with proximal femur fractures? A matched analysis of 5,030 patients with a median of 2.5 years' follow-up between 2006 and 2016 in the Nordic Arthroplasty Register Association
    Tsikandylakis, Georgios
    Karrholm, Johan N.
    Hallan, Geir
    Furnes, Ove
    Eskelinen, Antti
    Makela, Keijo
    Pedersen, Alma B.
    Overgaard, Soren
    Mohaddes, Maziar
    ACTA ORTHOPAEDICA, 2020, 91 (04) : 401 - 407
1234